Menu
    0

    YEARS OF RESEARCH

    in developmental psychology

    0

    PERCENT

    of children globally are identified as having severe attention difficulties

    0

    PERCENT

    of Australian children start school with reduced attention capacity

    0

    BILLION

    is the estimated annual cost to the Australian economy

    Latest News and Events

    TALi Appoints New Chief Medical Officer

    TALi has appointed Mary Elizabeth Brinson as its new Chief Medical Officer. Dr Brinson was former Vice President, Global Clinical Affairs, with medical devices leader Cochlear Limited. Dr Brinson will have overall ...

    Read more...

    Akili Interactive Named Among 10 Most Innovative by Fast Company

    TALi partner Akili Interactive has been named one of the 10 Most Innovative Companies in Medicines and Therapeutics for 2022 by Fast Company magazine in the United States.

    Read more...

    TALI Patent Granted in New Zealand

    We’re pleased to say we’ve been granted a patent for our attention assessment and training program in New Zealand. This new patent joins those we have in the United States, Australia and Japan, with other jurisdictions ...

    Read more...
    COMPANY INTRODUCTION

    COMPANY INTRODUCTION

    The vision for the TALi Digital is to position itself at the forefront of innovative medical technologies with TALi Health as the foundation product for the future.
    TALi Health is in the process of commercialising TALi TRAIN, final phases of development for TALi DETECT while simultaneously seeking alternative investment opportunities to capitalise on innovative medical technologies as it seeks to build a sustainable and viable business model for shareholders.

    INNOVATIVE TECHNOLOGY

    TALi has been hailed as a leading example of industry and research collaboration.

    GROUND BREAKING

    TALi Train and TALi Detect for young children based on 25 years of research in cognitive skill development in neurodiverse populations.

    SUPPORTIVE STATISTICS

    Globally, approximately 136 million children have been diagnosed with a disorder symptomatic attention deficit.

    TALi ASSESSMENT& TRAINING

    TALi apps assess and exercise core attention-related cognitive skills, a non-invasive alternative to conventional strategies.

    ENGAGEMENT

    TALi Health strives to conduct more high quality research to assess the full potential of the TALi technology.

    SCIENCE & RESEARCH

    Five peer-reviewed papers have been published that report the significant benefit of TALi Train for both neurodiverse and neurotypical children.

    Five-week clinical intervention

    TRAINING PROGRAM

    Designed as a five-week clinical intervention, the program is accessed via an off-line, home-based tablet, making it available to users across a wider range of socio-demographic groups and geographic locations.

    Evidence Based

    INNOVATIVE TECHOLOGIES

    The benefits of TALi were evaluated in a gold standard clinical trial. This research is published in highly regarded international journals.

    Constantly challenged

    ADAPTIVE

    TALi adapts to each individual child’s game play to ensure they are constantly challenged.

    TALi TECHNOLOGY

    TALi Health Pty Ltd is based in Melbourne, Australia and is made up of a team of neuroscientists, software engineers, game developers and all-round talented individuals. Our vision is to be a leader in the assessment and treatment of childhood attention difficulties. We aim to assist children in reaching their full potential by providing engaging training software clinically proven to improve core cognitive performance. Under the leadership of the TALi Digital Ltd Board of Directors , scientific advisory board and our team of experts design, develop, and evaluate training exercises that target core issues in early childhood and academic skills.

    QUICK CONTACT

    Our friendly and knowledgeable team stands ready to answer your questions and help you find the solutions that best suit your needs.

    Contact Us
     

    TALi Digital Limited (ASX: TD1) is an Australian Medical Technology Company listed on the Australian Securities Exchange.
    TALi Digital’s core focus is the development of TALi Health and the TALi Technology.

    Level 5, 19 William Street, Cremorne, VIC 3121 info@talihealth.com talidigital.com

    Terms & Conditions

    TALi Health

      Copyright 2022 TALi Digital Limited